13D Filing: Diker Charles M and Cantel Medical Corp (NYSE:CMD)

Page 1 of 5

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Charles M. Diker 3,256,687 571,326 3,256,687 1,316,680 4,573,367 10.9%

Page 1 of 5 – SEC Filing









Washington, D.C. 20549









Under the Securities Exchange Act of 1934
(Amendment No. 23)*


Cantel Medical Corp.

(Name of Issuer)


Common Stock $.10 par value per share

(Title of Class of Securities)



(CUSIP Number)


Mr. Charles M. Diker

730 Fifth Avenue, 15th Floor

New York, NY 10019

(212) 904-0321

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)


With a copy to:
Mr. Eric W. Nodiff

Cantel Medical Corp.

150 Clove Road

Little Falls, NJ 07424

(973) 890-7220


March 17, 2017

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


Follow Cantel Medical Corp (NYSE:CMD)

Page 1 of 5